|Re --Ginseng Viral Care--|
There was that CMAJ article on the double blind ginseng trials which proved its efficacy against the common cold and flu:
CV Technologies was the company involved in the CMAJ article.
They have a product containing ginseng extract that is sold widely to ward off the common cold and flu. It is called COLD-fX. This is their web site:
This is the stock symbol - CVQ.V:
Note the continual rise from Jan/03 at pennies to $4 today. Thanks to ginseng! I don't see why RSHN should do anything less!
This is the relevant US patent involved:
United States Patent 6,432,454
Shan , et al. August 13, 2002
Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
Inventors: Shan; Jacqueline J. (Edmonton, CA); Pang; Peter K. T. (Edmonton, CA); Huang; Buhan (Edmonton, CA); Ling; Lei (Edmonton, CA)
Assignee: C. V. Technologies, Inc. (Edmonton, CA)
Appl. No.: 581161
Filed: July 27, 2000
PCT Filed: November 11, 1998
PCT NO: PCT/US90/25724
RSHN will zing with ginseng!
Get ready to rumble.
I also follow and own shares in another immunostimulant company named Artec - ATKJ - which has an immunostimulant product called Tubercin very likely a terrific cancer fighting drug. I contemplated a link between RSHN and ATKJ to link Rush ginseng and Tubercin here:
Will it fly?
I hope so. BWDIK.